Sequential dose-intensive paclitaxel plus ifosfamide and carboplatin plus etoposide with autologous stem cell transplantation for germ cell tumor (GCT) patients (pts).

被引:0
|
作者
Kondagunta, GV [1 ]
Bacik, J [1 ]
Bajorin, DF [1 ]
Reich, L [1 ]
Sheinfeld, J [1 ]
Bains, M [1 ]
Bosl, GJ [1 ]
Motzer, RJ [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:378S / 378S
页数:1
相关论文
共 50 条
  • [31] Superior autologous blood stem cell mobilization (BSCM) with dose-intensive cyclophosphamide, etoposide, cisplatin (DICEP) plus G-CSF than with less intensive chemotherapy (CT) plus G-CSF
    Stewart, DA
    Guo, D
    Brown, C
    Poon, MC
    Ruether, B
    Jones, A
    Klassen, J
    Luider, J
    Morris, D
    Chaudhry, A
    Russell, JA
    BLOOD, 1997, 90 (10) : 433 - 433
  • [32] Superior autologous blood stem cell mobilization from dose-intensive cyclophosphamide, etoposide, cisplatin plus G-CSF than from less intensive chemotherapy regimens
    Stewart, DA
    Guo, D
    Morris, D
    Poon, MC
    Ruether, BA
    Jones, AR
    Klassen, J
    Auer, I
    Luider, J
    Chaudhry, A
    Brown, C
    Russell, JA
    BONE MARROW TRANSPLANTATION, 1999, 23 (02) : 111 - 117
  • [33] Treating relapsed and refractory metastatic germ cell tumours with high-dose chemotherapy with carboplatin and etoposide and autologous haematopoietic stem cell transplantation
    Erturk, Ismail
    Karadurmus, Nuri
    Kiziloz, Halil
    Acar, Ramazan
    Yildiz, Birol
    Aykan, Musa Baris
    Esen, Ramazan
    Buyukturan, Galip
    Urun, Yuksel
    Erdem, Gokhan
    Arpaci, Fikret
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (07) : 1657 - 1664
  • [34] Superior autologous blood stem cell mobilization from dose-intensive cyclophosphamide, etoposide, cisplatin plus G-CSF than from less intensive chemotherapy regimens
    DA Stewart
    D Guo
    D Morris
    M-C Poon
    BA Ruether
    AR Jones
    J Klassen
    I Auer
    J Luider
    A Chaudhry
    C Brown
    JA Russell
    Bone Marrow Transplantation, 1999, 23 : 111 - 117
  • [35] CUTANEOUS TOXICITY OF HIGH-DOSE CARBOPLATIN, ETOPOSIDE AND IFOSFAMIDE FOLLOWED BY AUTOLOGOUS STEM-CELL REINFUSION
    BEYER, J
    GRABBE, J
    LENZ, K
    WEISBACH, V
    STROHSCHEER, I
    HUHN, D
    SIEGERT, W
    BONE MARROW TRANSPLANTATION, 1992, 10 (06) : 491 - 494
  • [36] Phase I study of high-dose ifosfamide, carboplatin and etoposide with autologous hematopoietic stem cell support
    Lotz, JP
    Izrael, V
    BONE MARROW TRANSPLANTATION, 1995, 16 (06) : 858 - 859
  • [37] Ofatumumab Plus Ifosfamide/Etoposide (OIE) Followed By Autologous Stem Cell Transplantation (ASCT) in Patients with b-Cell Non-Hodgkin's Lymphomas (NHL)
    Khouri, Issa F.
    Turturro, Francesco
    Milton, Denai R.
    Korbling, Martin
    Samuels, Barry I.
    Jabbour, Elias J.
    Ledesma, Celina
    Valverde, Rosamar B.
    Gao, Hui
    Fanale, Michelle A.
    Fayad, Luis E.
    Nastoupil, Loretta J.
    Reuben, James M.
    Gulbis, Alison M.
    BLOOD, 2016, 128 (22)
  • [38] Long-term results of first-line sequential high-dose carboplatin, etoposide and ifosfamide chemotherapy with peripheral blood stem cell support for patients with advanced testicular germ cell tumor
    Miki, Tsuneharu
    Mizutani, Yoichi
    Akaza, Hideyuki
    Ozono, Seiichiro
    Tsukamoto, Taiji
    Terachi, Toshiro
    Naito, Katsusuke
    Nonomura, Norio
    Hara, Isao
    Yoshida, Osamu
    INTERNATIONAL JOURNAL OF UROLOGY, 2007, 14 (01) : 54 - 59
  • [39] DOSE-INTENSIVE THERAPY WITH AUTOLOGOUS BLOOD STEM-CELL TRANSPLANTATION IN BREAST-CANCER
    KOTASEK, D
    SAGE, RE
    DALE, BM
    NORMAN, JE
    BOLTON, A
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1994, 24 (03): : 288 - 295